stockrow
Friday 6 November 2026
Export CC’s income statement to Excel — free account
The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
12.82
0.97
−7.03%
Follow CC
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.31 | 0.57 | 0.54 | 0.35 | |
P/FCF ratio |
34.73 | 21.57 | 14.23 | 10.07 | |
P/Operating CF |
12.93 | (75.49) | 19.64 | 13.78 | |
P/B ratio |
7.06 | 15.38 | 0.00 | 13.16 | |
Price to Tangible BV |
8.73 | 19.77 | 0.00 | 19.01 | |
EV/Sales |
0.90 | 1.18 | 1.09 | 0.88 | |
EV/EBITDA |
18.26 | 27.47 | 29.05 | 23.72 | |
EV/Operating CF |
19.85 | 20.77 | 15.88 | 12.87 | |
EV/FCF |
102.75 | 44.78 | 28.92 | 25.23 | |
Quick Ratio |
0.80 | 0.82 | 0.85 | 0.93 | |
Current Ratio |
1.78 | 1.82 | 1.66 | 1.81 | |
Net Debt/EBITDA |
54.20 | 33.09 | (24.44) | 0.00 | |
Debt/Assets |
56.10% | 56.93% | 54.15% | 52.56% | |
Debt/Equity |
16.50 | 19.15 | (80.67) | 24.57 | |
Asset Turnover |
0.78 | 0.79 | 0.79 | 0.79 | |
Operating CF/Net income |
(2.91) | 1.52 | (0.58) | 0.76 | |
Capex/Depreciation |
(0.63) | (0.60) | (0.54) | (0.61) | |
Interest Coverage |
(0.28) | 0.38 | (3.13) | 3.32 | |
Research and Development Expense of Revenue |
2.03% | 1.88% | 1.70% | 1.56% | |
Selling, General and Administrative Expense of Revenue |
10.75% | 10.64% | 29.48% | (1.62%) | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.30% | 0.51% | 0.44% | 0.26% | |
Graham Net Nets |
(2.33) | (1.24) | (1.32) | (1.91) | |
Graham Number |
0.00 | 0.00 | 3.70 | 0.00 | |
Earnings Yield |
(21.06%) | (11.99%) | (9.32%) | (7.50%) | |
Free Cash Flow Yield |
2.88% | 4.64% | 7.03% | 9.93% | |
Revenue per Share |
8.85 | 9.16 | 10.52 | 10.18 | |
Operating CF per Share |
0.91 | (0.29) | 1.04 | 0.98 | |
Capex per Share |
(0.35) | (0.32) | (0.29) | (0.34) | |
Free Cash Flow per Share |
0.57 | (0.62) | 0.75 | 0.65 | |
Cash per Share |
4.47 | 3.73 | 4.44 | 4.88 | |
Shareholders Equity per Share |
1.67 | 1.43 | (0.32) | 1.03 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.67 | 1.43 | (0.32) | 1.03 | |
Free Cash Flow |
85.00 | (93.00) | 114.00 | 98.00 | |
Working Capital |
1,315.00 | 1,319.00 | 1,233.00 | 1,442.00 | |
Capital Expenditures |
(52.00) | (49.00) | (44.00) | (51.00) | |
Net Current Asset Value |
(4,130.00) | (4,123.00) | (4,104.00) | (3,918.00) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 223.81 | |
Capex to Sales |
0.04 | 0.04 | 0.03 | 0.03 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 89.29 | |
| Other line items | |||||
Average Receivables |
724.50 | 808.50 | 933.00 | 934.50 | |
Average Payables |
1,055.00 | 948.50 | 980.00 | 1,015.00 | |
Average Inventory |
1,516.00 | 1,543.00 | 1,505.00 | 1,511.00 | |
Average Assets |
7,445.50 | 7,330.50 | 7,319.00 | 7,431.50 | |
Average Common Equity |
411.50 | 398.00 | 95.50 | 228.00 |
Columns are period end dates · fundamentals updated 5 Nov 2026